New methods and formulation of estrous synchronization

Researchers at the University of Saskatchewan have developed and tested a novel method for controlling ovarian function and synchronizing ovulation in mammals. A new pharmaceutical composition was developed and incorporated into commercially available intravaginal devices. The method and formulation employs aromatase inhibitors, which have high efficacy, few side-effects, and established safety.